Cypress Growth Capital Invests in CustomerInsights.ai

Cypress Growth Capital is excited to announce our recent investment in CustomerInsights.ai (CIAI), a Scottsdale, AZ–based technology company that helps life sciences organizations make smarter business decisions using its AI-powered software and consulting services.

The prescription drug market is one of the most complex industries in the U.S., shaped by clinical requirements, patient needs, consumer behavior, and insurance dynamics. Successful market insights depend on the ability to overlay complex decision models on massive data sets. CIAI’s proven platform, coupled with their consultative expertise, does exactly that - and its growth reflects their differentiated customer value. Revenue has increased 40% per year over the past three years, and the company is well-positioned to thrive in the rapidly evolving AI landscape.

“We were looking for a capital partner that would add value in the critical next phase of our company. The operating and entrepreneurial experience of Cypress’s team was a key part of our decision.”

Co-Founder and CEO of CIAI - Abhay Jajoo

Abhay said, “Our value in the market is proven and our growth outlook is very strong. We raised capital to expand our reach. But more importantly, we were looking for a capital partner that would add value in the critical next phase of our company. The operating and entrepreneurial experience of Cypress's team was a key part of our decision.”

The deep industry knowledge of CIAI’s team was a major factor in Cypress’s investment decision. “CustomerInsights.ai is a leader in a rapidly growing market,” said Vik Thapar, Managing Director of Cypress. “Abhay, Robin, and the CIAI team have translated their years of hands-on experience at the leading edge of pharmaceutical data into a powerful technology platform and specialized consulting services. The company is transforming how life sciences companies make key market decisions. We’re proud to partner with the team as they continue to grow.”

Cypress’s non-dilutive growth capital will be invested in marketing, sales, and agentic AI expansion.